About Us .

Qianhui Biotechnology

Zibo Qianhui Biotechnology Co., Ltd., founded in 2006 and located in Polymer Industrial Park in Zibo High-tech Zone, is a high-tech enterprise integrating scientific research, production and sales. 

The company specializes in production of pharmaceutical excipients, food and cosmetic additives that consist mainly of cyclodextrin and its derivative. Sulfobutyl ether beta cyclodextrin sodium, a new injectable excipient independently researched and developed by the company, is the first new excipient (registered as “A”) passing technical review with associated drug product and fills in the market gap in China. CDE platform - pharmaceutical excipient registration No.: F20180000620, U.S. FDA registration No.: DMF 29394. Hydroxypropyl-beta-cyclodextrin, CDE platform - pharmaceutical excipient registration No.: F20209990335 (oral administration, activated, Lu Yao Zhun Zi F2012004), F20180000146 (oral administration) and F20180000895 (injection), U.S. FDA registration No.: DMF 033403. It has been widely applied and approved in domestic and foreign markets.

img
1
2

Products Display.

LEADER OF CYCLODEXTRIN

04
Betadex Sulfobutyl Ether Sodium
Betadex Sulfobutyl Ether Sodium
Hydroxypropyl Beta Cyclodextrin
Hydroxypropyl Beta Cyclodextrin
Dimethyl Beta Cyclodextrin
Dimethyl Beta Cyclodextrin
2,6-Dimethyl Beta Cyclodextrin
2,6-Dimethyl Beta Cyclodextrin

Business Advantage

04

LEADER OF CYCLODEXTRIN

The company specializes in production of pharmaceutical excipients, food and cosmetic additives that consist mainly of cyclodextrin and its derivative. Sulfobutyl ether beta cyclodextrin sodium, a new injectable excipient independently researched and developed by the company, is the first new excipient (registered as “A”) passing technical review with associated drug product and fills in the market gap in China. CDE platform - pharmaceutical excipient registration No.: F20180000620, U.S. FDA registration No.: DMF 29394. Hydroxypropyl-beta-cyclodextrin, CDE platform - pharmaceutical excipient registration No.: F20209990335 (oral administration, activated, Lu Yao Zhun Zi F2012004), F20180000146 (oral administration) and F20180000895 (injection), U.S. FDA registration No.: DMF 033403. It has been widely applied and approved in domestic and foreign markets.

01

Standardized production workshop

02

Professional testing equipment

03

High standard specification system

04

Fill the gap in the market

Technological Innovation

Adhering to the concept of treating product quality as enterprise life, the company enhances risk management and sets up and completes the quality management system as per the requirements of GMP. 

 

1. Set up a complete quality management system based on the concept of risk management to control the whole production process. 

2. Implement GMP for pharmaceutical excipients and medical products actively. 

3. Carry out validation of production process and key production equipment. 

4. Implement quality authorized person system and release products by the authorized person. 

 

Zhuangye Machine

News

Contact Us

Username used for comment:
客户留言
Description:
验证码

COPYRIGHT © 2021 Zibo Qianhui Biological Technology Co., Ltd.    鲁ICP备16006179号-6   Powered by 300.cn  

EWM

How can I help you?

0086-533-3780067